HCP5 and gastric cancer: Besides, compared with single detection, combined detection can better distinguish GC patients from healthy donors, especially when compared with the combined diagnosis model of HCP5, CEA, and CA199, the combination of which can increase sensitivity and specificity, which could reach 81% and 79%, respectively (Table 2).